FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, an esteemed journal published by VIA MEDICA, serves as a vital platform for researchers and professionals in the fields of histology, pathology, and cytobiology. With an ISSN of 0239-8508 and E-ISSN of 1897-5631, this Open Access journal has been disseminating significant findings since 1984, offering free access to a broad audience of scientists and academics. Based in Poland, this journal focuses on critical advancements in the study of cellular structures and functions, contributing substantially to the understanding of various diseases and biological processes. The journal currently holds a respectable impact factor, ranking in the Q3 category for Histology and miscellaneous Medicine, and Q2 for Pathology and Forensic Medicine as per the 2023 metrics. With its commitment to quality research and an inclusive publishing approach, FOLIA HISTOCHEMICA ET CYTOBIOLOGICA is poised to continue influencing its fields significantly through 2024 and beyond.

LABORATORY ANIMALS is a premier journal published by SAGE PUBLICATIONS INC, dedicated to advancing the field of laboratory animal science. With an impressive impact factor that places it in the Q1 quartile for both Animal Science and Zoology, and Veterinary disciplines, it ranks remarkably at #13 out of 194 in General Veterinary and #62 out of 490 in Animal Science on Scopus. Established in 1970 and set to continue its trajectory until 2024, the journal covers a wide range of topics relevant to researchers, professionals, and students interested in the ethical and scientific use of laboratory animals. Although it operates under a traditional subscription model, its high-quality publications provide essential insights into veterinary practices, animal welfare, and translational research. The journal serves not only as a critical resource for contemporary research but also as a platform for dialogue on best practices in laboratory animal care, making it indispensable for anyone invested in the advancement of veterinary and animal sciences.

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

Comparative Medicine, published by the American Association for Laboratory Animal Science, serves as a vital resource in the fields of veterinary science and biochemistry, focusing on the complexities of laboratory animal research and its implications for human and animal health. Established in 2000 and continuing through 2024, this journal has cultivated a reputation for disseminating innovative research and reviews that enhance understanding of comparative biology and medicine. With a commendable Q3 rank in both Biochemistry, Genetics and Molecular Biology and Medicine, and a notable Q2 rank in Veterinary sciences as of 2023, it stands out in its field. The journal is dedicated to open access, aligning with contemporary trends in scientific communication, and its impact can be appreciated in its Scopus ranks, placing it in the 59th percentile for General Veterinary and the 36th percentile for General Biochemistry, Genetics, and Molecular Biology. Researchers, professionals, and students will find this journal indispensable for staying informed on cutting-edge advancements and fostering cross-disciplinary dialogue in comparative medicine.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

Welcome to the Korean Journal of Physiology & Pharmacology, a pivotal academic platform dedicated to advancing the disciplines of physiology and pharmacology. Published by the esteemed Korean Journal of Physiology & Pharmacology, this journal has been disseminating valuable research findings since its inception in 1997 and continues to be a critical resource for researchers, professionals, and students in South Korea and beyond. With an ISSN of 1226-4512 and E-ISSN of 2093-3827, it offers insights into various aspects of drug action and physiological mechanisms. Although this journal currently does not subscribe to Open Access, it plays a vital role in bridging the gap between experimental and clinical studies, receiving commendations for its quality. In the 2023 Scopus rankings, it is notably positioned in the Q3 quartile for Pharmacology and Q4 for Physiology, reflecting its commitment to excellence. As the journal converges towards its comprehensive coverage in 2024, it remains a cornerstone for those looking to engage deeply with critical developments in these fields.

Laboratory Animal Research is a prominent academic journal dedicated to advancing the field of laboratory animal science, providing a platform for researchers, professionals, and students focused on biochemistry, genetics, and molecular biology. Published by SPRINGERNATURE, this journal is recognized for its rigorous peer-review process and commitment to high-quality research, achieving a notable Q2 ranking in the Biochemistry, Genetics and Molecular Biology category as of 2023. Since becoming an Open Access journal in 2015, Laboratory Animal Research has fostered greater accessibility and dissemination of research findings, encouraging collaboration and innovation within the scientific community. With its ISSN 1738-6055 and E-ISSN 2233-7660, the journal is based in the United Kingdom and resides at CAMPUS, 4 Crinan St, London, N1 9XW, England. It is an essential resource for anyone involved in laboratory animal research and strives to enhance the welfare and scientific use of animals in research settings.

Current Reviews in Clinical and Experimental Pharmacology is a cutting-edge journal published by Bentham Science Publishers in the United Arab Emirates, focusing on the dynamic field of pharmacology. With an ISSN of 2772-4328 and an E-ISSN of 2772-4336, this journal has rapidly established itself as a significant resource for researchers and professionals in the medical and pharmaceutical sciences since its inception in 2021. It boasts an impressive Q3 ranking in Pharmacology (medical) and Q2 in the Pharmacology, Toxicology and Pharmaceutics (miscellaneous) category as of 2023. Furthermore, it ranks #14/80 in general pharmacology, reflecting its esteemed position within the scientific community. As an Open Access publication, it ensures that groundbreaking research is readily accessible, fostering collaboration and innovation. The journal invites high-quality reviews and original articles that address contemporary issues and advancements in clinical and experimental pharmacology, making it an essential venue for disseminating knowledge and engaging with emerging trends in therapeutic developments.

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE is a leading peer-reviewed publication dedicated to advancing the frontiers of experimental medicine and biomedical research. Published by TOHOKU UNIV MEDICAL PRESS in Japan, this journal has been a vital source of knowledge for over a century, with its historical span ranging from 1920 to 2024. As a Q2 journal in Biochemistry, Genetics and Molecular Biology and Q3 in Medicine, it boasts an impressive Scopus ranking of 144 out of 636 in General Medicine, thereby signifying its strong influence in the field. The journal aims to disseminate critical findings and innovative research methodologies, fostering a collaborative environment among researchers, clinicians, and students. Despite its traditional publishing model, the journal remains committed to contributing significantly to the global scientific community, ensuring that groundbreaking discoveries and experimental techniques are shared with a wide audience, ultimately enhancing healthcare and therapeutic strategies.

LAB ANIMAL, a journal published by NATURE PORTFOLIO, is a prominent source of knowledge in the fields of animal science and veterinary medicine. With its ISSN 0093-7355 and E-ISSN 1548-4475, it serves as a critical platform for researchers, professionals, and students dedicated to the advancement of laboratory animal science. Despite being categorized in the Q4 quartile for Animal Science and Zoology and Q3 for Veterinary (Miscellaneous) in 2023, its contributions are invaluable, reflecting rigorous research and development essential for improving laboratory animal care and ethical research practices. The journal aims to foster innovation and responsive dialogue in an evolving landscape of animal research, promoting a more humane and scientifically sound approach. Although it currently operates under a subscription-based model, LAB ANIMAL continues to be an essential resource for the academic community, providing insights that are integral to advancing both veterinary and animal sciences. The journal has consistently published research since its inception in 1995, engaging a diverse audience with comprehensive studies and discussions that impact the future of the field.